Frontiers in Immunology Submission Guide (2026)

Most current Frontiers in Immunology submission pages summarize broad Frontiers mechanics: choose an article type, select a specialty section, follow author guidelines, and complete open-access submission. That helps with portal compliance, but it misses the section-level editorial decision.

This guide gives you the decision layer beyond official publisher instructions. Frontiers itself makes authors choose a specialty section and only offers article types available for that section. The practical screen is whether the abstract, contribution statement, methods, cohort table, section selection, and data availability language make the immunology relevance and section fit obvious before collaborative review starts.

Evidence basis and source limitations: this page uses public Frontiers guidance and Manusights pre-submission patterns; it is not a private live Frontiers submission-session test. Official publisher instructions cannot tell whether the selected specialty section, cohort table, methods, and contribution statement will satisfy the section editor. What editors actually screen for is section-level fit before collaborative review.

If you want the quick pre-upload call, run a Frontiers in Immunology manuscript fit check before opening the Frontiers submission platform.

Submit if your paper fits these criteria: clinical immunology with patient data, systematic reviews with rigorous methodology, or translational research connecting bench findings to clinical outcomes. Each specialty section has its own Associate Editors and community reviewers, so section choice matters almost as much as paper quality.

Don't submit basic mechanistic studies without clinical context. In our experience, the journal's reviewers and editors respond more to translational impact than to novel molecular mechanisms alone, although its scope also covers basic immunology. If your paper describes a new pathway but doesn't connect to disease or therapy, consider Journal of Immunology instead.

The collaborative review model means constructive feedback, but editors filter aggressively for scope fit. Check the journal's positioning, section mix, and recent publications before deciding whether it aligns with your goals.

Source: Frontiers in Immunology Author Guidelines, Article Types, Publishing fees, accessed October 2026; 2026 JCR release, accessed May 2026.

Frontiers in Immunology editorial workflow at the Frontiers submission platform (Frontiersin submission portal) follows Frontiers' published collaborative review stages. Frontiers does not publish a day-by-day schedule or a median time to first decision, so the stages below carry only the deadlines Frontiers states. In our pre-submission work, editors screen for translational / clinical relevance, specialty-section fit, and methodological rigor in the first read.

• Pre-screening: After submission, the Frontiers editorial office pre-screens the manuscript for research integrity and quality standards. Frontiers says manuscripts with incomplete or incorrect data availability statements are prevented from entering the review process, and article types are limited to those offered for the selected specialty section.
• Specialty-section editor assignment: If the manuscript meets Frontiers' quality criteria, an editor from the relevant specialty section is invited to handle it. Submitting authors can name a preferred Associate Editor, with no guarantee, and the Chief Editor can reassign the manuscript at any stage.
• Preliminary content check: The handling editor decides whether to send the manuscript for review or to recommend immediate rejection to the specialty chief editor, for example for objective errors in the methods, ethical issues, or a manuscript that does not fit the journal's standards.
• Independent review: Most article types need at least two reviewers. Reviewers are asked to submit their independent reports within seven to ten days after accepting (Frontiers' editor guidelines say seven days and its peer review guidelines say ten). Frontiers uses a single anonymized model, and the names of reviewers who endorse publication appear on the published article.
• Interactive review: Authors are asked to respond or submit a revised manuscript within seven, 10 or 14 days, depending on the level of revisions the editor requests. Reviewers recommend to reject, revise or accept, and the review is complete only once all reviewer and editor comments have been addressed.

The Frontiers submission checklist and author guidelines ask for the following items at the Frontiers platform (Frontiersin submission portal).

The required artifacts are:

• the 200-word contribution-to-the-field statement for non-expert readers (Frontiers does not accept a traditional cover letter; list any preprint in the acknowledgments and the reference list)

• the manuscript source file (Word or LaTeX) and the PDF generated from it, using the Frontiers templates

• the 200-word scope-and-relevance statement at submission

• the 5-8 keywords

• the specialty-section assignment (load-bearing)

• the author contributions statement

• the conflicts of interest declaration

• the funding statement and source listing

• the data availability information (Frontiers generates the statement from the submission form, and mandatory data types go in public repositories)

• the ethics approval and consent information (IRB / IACUC for human / animal work)

• the acknowledgment of any generative AI use

• the supplementary information (extended methods, additional figures, datasets)

Frontiers in Immunology operates through 25 specialty sections, each with its own Associate Editors and community reviewers. You don't just submit to "Frontiers in Immunology." You submit to a specific section such as Cancer Immunity and Immunotherapy, Autoimmune Disorders, or Mucosal Immunity.

• Examples of section names:

• Cancer Immunity and Immunotherapy

• Autoimmune Disorders and Autoinflammatory Disorders (two separate sections)

• Inflammation

• Immunological Memory

• Vaccines and Molecular Therapeutics

• Nutritional Immunology

Frontiers publishes no section-level selectivity figures in the pages we reviewed, and it states that it does not set a rejection rate, formal or informal.

Choose your section carefully. Each section has its own Associate Editors and community reviewers, and your manuscript is peer-reviewed by those of the section you select.

• Section selection strategy:

Read the last 6 months of papers in your target section. Match the study design, sample size, and clinical context. If most papers in your target section have 200+ patients and yours has 45, consider whether another section is a better fit.

Submitting authors can name a preferred Associate Editor, with no guarantee, and the Chief Editor can assign a new Associate Editor to a manuscript at any stage.

If you have a meta-analysis of immunotherapy trials, Cancer Immunity and Immunotherapy is the section whose name matches. For basic T-cell biology without cancer context, T Cell Biology or Immunological Tolerance and Regulation may fit.

The section structure matters more at Frontiers than at traditional journals. Nature Immunology editors handle scope decisions centrally. At Frontiers, the specialty section editor makes the initial call. Pick the right section, and you're talking to someone who understands your specific research area.

The submitting and corresponding authors must register with Frontiers before submitting, and the submitting author enters the names, emails and affiliations of all authors. The Frontiers submission checklist does not list ORCID IDs as a requirement.

• Required documents:

• Manuscript file (LaTeX or Word) and the PDF generated from it

• Figure files (300 dpi at final size, TIFF or JPEG, RGB)

• Data availability statement (generated from your answers in the submission form)

• Competing interests declaration

• Ethics information (committee name and affiliation, consent details)

• Formatting specifics:

Word limit varies by article type. Original Research allows 12,000 words, excluding the abstract, captions, funding statement, acknowledgments and references. Reviews and Methods articles are also capped at 12,000 words. Frontiers asks you to state your word, figure and table counts on the first page of the manuscript.

Frontiers asks for figures to be submitted individually, in the order they are cited, and embeds them at the end of the submitted manuscript. If the article is accepted, the production office might require high-resolution files in EPS, JPEG or TIF/TIFF format.

Frontiers does not accept a traditional cover letter, so put the research question, key findings and the clinical relevance in the 200-word contribution and scope statements. Use these cover letter examples only as a model for concise framing, and customize for Frontiers' collaborative review philosophy.

• Submission checklist:

• Submitting and corresponding authors registered with Frontiers

• Specialty section selected

• Word count within limits

• Ethics approvals documented

• Data sharing plan included

• Competing interests declared

Triple-check your specialty section choice before final submission.

Frontiers does not publish an average time to first decision for this journal. Timing depends on reviewer recruitment and on how many rounds of interactive review the manuscript needs.

• Stages with published deadlines:

• Independent review: reviewers are asked to submit their reports within seven to ten days after accepting (Frontiers' editor guidelines say seven days and its peer review guidelines say ten)

• Interactive review: authors respond or submit a revised manuscript within seven, 10 or 14 days, depending on the revisions the editor requests

• Article processing charge: payable within 30 days of acceptance

The collaborative review model lets reviewers see each other's comments and build consensus in the interactive review forum. You'll get more constructive feedback than adversarial criticism. Reviewers know their comments are shared, which tends to make reviews more professional and helpful.

• During review:

You can follow your manuscript through your Frontiers account. For queries about a manuscript in review, Frontiers lists immunology.editorial.office@frontiersin.org.

If the authors are unresponsive to multiple communication attempts, the editorial office sends a final email with a seven-day deadline and reserves the right to withdraw the manuscript from the review process.

• Revision strategy:

Address every reviewer comment specifically. The collaborative model means reviewers will see your response and judge whether you've addressed their concerns adequately. Don't dismiss any feedback, even if you disagree.

The biggest mistake is assuming Frontiers has lower standards because the journal publishes at scale. The broader scope changes throughput, but editors still filter hard for translational relevance, section fit, and methodological credibility.

• Top rejection triggers:

1. Poor clinical context - Describing molecular mechanisms without connecting to disease or therapy

1. Weak systematic review methodology - Missing PROSPERO registration, inadequate search strategies, no quality assessment

1. Wrong specialty section - Submitting autoimmune disease research to a section that does not match, such as Cancer Immunity and Immunotherapy

Authors often submit basic immunology papers because they think Frontiers will accept anything. In our experience, the journal's editors and reviewers look for translational relevance, not just novel biology. If your T-cell study doesn't connect to autoimmune disease, cancer, or vaccines, try a basic immunology journal instead.

Systematic reviews fail when methodology is sloppy. Register your protocol with PROSPERO before starting. Use multiple databases for literature searches. Include quality assessment tools like Newcastle-Ottawa or Cochrane risk-of-bias. The journal publishes many systematic reviews, but only rigorous ones.

• Original Research: Clinical studies, translational research, biomarker validation. In our experience, basic mechanistic studies fare better with a clear clinical or translational link, although the journal's scope also covers basic immunology. Sample sizes matter less than study design quality.

• Reviews: Systematic reviews and meta-analyses perform better than narrative reviews. PRISMA compliance is mandatory for the Systematic Review article type. Expert opinion pieces rarely get accepted unless from recognized thought leaders.

• Clinical Trial: Phase I-III trials, real-world effectiveness studies, post-market surveillance data. Requires trial registration and follows CONSORT guidelines.

• Methods: New techniques, protocols, or analytical approaches. Must demonstrate advantage over existing methods with validation data.

Success varies by article type and section. Systematic reviews often perform better when methodology is strong, while original research and clinical trial papers face more direct scrutiny on section fit, ethical handling, and translational value.

Position your work appropriately. Don't submit a narrative review when you could do a systematic review. Don't call a case series "original research" when it belongs in Clinical Trial category.

Compare options based on your career stage and research type. Consider these factors when choosing journals alongside Frontiers' specific strengths and limitations.

• Choose Nature Immunology if: Your basic research has broad immunological significance, you have strong mechanistic data, and you can wait 6+ months for review.

• Choose Immunity if: You're reporting paradigm-shifting findings, have comprehensive experimental validation, and prioritize prestige over publication speed.

• Choose Journal of Immunology if: Your work is solid basic immunology without clinical connection, you prefer traditional peer review, and you want faster publication than Nature journals.

• Choose Clinical Immunology if: Your research focuses specifically on clinical applications, you have patient data, and you want a specialized audience over broad readership.

Frontiers works best for translational research that connects basic findings to clinical relevance. If your paper sits between basic and clinical research, Frontiers offers a good middle ground with reasonable review times and constructive feedback.

The collaborative review model suits early-career researchers who benefit from detailed, educational feedback. Senior researchers who prefer traditional anonymous review might find other journals more comfortable.

Before you upload, run your manuscript through a Frontiers in Immunology submission readiness check to catch the issues editors filter for on first read.

For manuscripts targeting Frontiers in Immunology, five patterns generate the most consistent desk rejections worth knowing before submission.

These patterns come from our pre-submission review work, not from a list of desk-rejection triggers published by Frontiers.

Basic immunology paper without a clinical or translational anchor

The Frontiers in Immunology author guidelines and the journal's About page describe a multidisciplinary journal covering basic, translational and clinical immunology, and the About page says manuscripts focused on clinical studies or human diseases without a clear connection to immunology are not suitable. In our pre-submission review work, we see many desk rejections involve manuscripts that describe novel molecular pathways or immune cell biology without connecting the findings to disease, therapy, or patient outcomes.

Editors specifically screen for manuscripts where the clinical or translational consequence is present in the framing, not implied from the mechanism alone.

Systematic review submitted without PROSPERO registration

We also often find many systematic review and meta-analysis submissions arrive without a registered protocol in PROSPERO or an equivalent prospective registration, or with search strategies and quality assessment tools missing from the supplementary materials. In practice, editors consistently reject systematic reviews where the methodology documentation is incomplete at submission, because Frontiers' Systematic Review article type requires a clearly defined research question (PICOS), a stated reporting guideline such as PRISMA, and a PRISMA flow diagram where applicable.

Specialty section choice misaligned with the immunology paper

A related pattern is that many submissions are routed to a specialty section whose editorial standards and reviewer pool do not match the manuscript's study design, patient population, or research question. Editors explicitly consider whether the specialty section fits the manuscript before accepting for review, because each section has its own Associate Editors and community reviewers.

Check specialty section choice misaligned with the immunology paper before submitting to Frontiers in Immunology →

Clinical study too small for the target specialty section's bar

A related pattern is that many submissions to clinically oriented sections arrive with patient cohort sizes that fall well below the sample sizes that section editors and reviewers expect for the clinical claims being made. In our analysis of submission difficulties at Frontiers in Immunology, this pattern is most common in submissions where the section was chosen for topic fit without checking the typical study scale in that section's recent publications.

Check clinical study too small for the target specialty section's bar before submitting to Frontiers in Immunology →

Scope statement explains the science but not the clinical consequence

A related pattern is that many submissions arrive with scope statements that describe the immunological mechanisms studied without stating what the findings mean for patient care, drug development, or clinical decision-making. Editors explicitly consider whether the scope statement makes the translational case before routing the paper for collaborative review.

SciRev author-reported review times and Clarivate 2026 JCR release bibliometric data provide additional benchmarks when planning your submission timeline.

Before submitting to Frontiers in Immunology, a Frontiers in Immunology submission readiness check identifies whether your translational framing, systematic methodology, and section choice meet the editorial bar before you commit to the submission.

Or see example reports before you finalize.

Check scope statement explains the science but not the clinical consequence before submitting to Frontiers in Immunology →

• Is Frontiers in Immunology a Good Journal? An Honest Assessment for 2026 - Use a fuller journal-evaluation page before deciding whether the fit is right

• Is Frontiers in Immunology a Good Journal? An Honest Assessment for 2026 - Reputation analysis and career considerations

• Journal Cover Letter Template: 5 Filled-In Examples for Any Journal - Cover letter templates and examples

Getting your manuscript ready for submission? Manusights provides detailed pre-submission reviews to catch formatting issues, scope mismatches, and editorial red flags before you submit.

Past the desk screen and into review? The Frontiers in Immunology Under Review status guide shows what to watch for and what to prepare while you wait.

Journal choice sets the ceiling on how the paper will be read. Compare my abstract's fit with Frontiers in Immunology before I reformat.

A revision is won or lost in the response letter: responding to Frontiers in Immunology reviewers.